Gw Pharma ADR (GWPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2016 | 09-2015 | 12-2014 | 09-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -90,679 | -68,303 | -5,300 | N/A | -4,660 |
| Depreciation Amortization | 5,224 | 3,528 | 760 | N/A | 500 |
| Accounts receivable | -1,073 | -1,548 | N/A | N/A | N/A |
| Other Working Capital | 22,325 | 17,812 | 2,570 | N/A | 1,800 |
| Other Operating Activity | -56,301 | -22,716 | -7,650 | 0 | -1,690 |
| Operating Cash Flow | $-120,504 | $-71,227 | $-9,620 | $N/A | $-4,050 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -12,362 | -27,456 | -9,180 | N/A | -1,420 |
| Purchase Sale Intangibles | -729 | -175 | N/A | N/A | N/A |
| Other Investing Activity | -111 | 187 | 60 | 0 | 70 |
| Investing Cash Flow | $-12,473 | $-27,269 | $-9,120 | $N/A | $-1,350 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -181 | -391 | N/A | N/A | N/A |
| Common Stock Issued | 295,000 | 197,750 | N/A | N/A | N/A |
| Other Financing Activity | -222 | -529 | 100 | 0 | 420 |
| Financing Cash Flow | $294,597 | $196,830 | $100 | $N/A | $420 |
| Exchange Rate Effect | 37,127 | 9,540 | 6,330 | N/A | 330 |
| Beginning Cash Position | 334,575 | 252,119 | 256,220 | N/A | 63,090 |
| End Cash Position | 533,321 | 359,993 | 243,920 | N/A | 58,440 |
| Net Cash Flow | $198,746 | $107,874 | $-12,300 | $N/A | $-4,640 |
| Free Cash Flow | |||||
| Operating Cash Flow | -120,504 | -71,227 | -9,620 | N/A | -4,050 |
| Capital Expenditure | -12,362 | -27,459 | N/A | N/A | N/A |
| Free Cash Flow | -132,866 | -98,686 | -9,620 | 0 | -4,050 |